1887
Rapid communication Open Access
Like 0

Abstract

Preliminary results for influenza vaccine effectiveness (VE) against acute respiratory illness with circulating laboratory-confirmed influenza viruses in New Zealand from 27 April to 26 September 2015, using a case test-negative design were 36% (95% confidence interval (CI): 11–54) for general practice encounters and 50% (95% CI: 20–68) for hospitalisations. VE against hospitalised influenza A(H3N2) illnesses was moderate at 53% (95% CI: 6–76) but improved compared with previous seasons.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.1.30101
2015-01-07
2024-04-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.1.30101
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/1/eurosurv-21-30101-4.html?itemId=/content/10.2807/1560-7917.ES.2016.21.1.30101&mimeType=html&fmt=ahah

References

  1. Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother. 2012;8(7):851-62.  https://doi.org/10.4161/hv.19917  PMID: 22777099 
  2. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36-44.  https://doi.org/10.1016/S1473-3099(11)70295-X  PMID: 22032844 
  3. Huang QS, Baker M, McArthur C, Roberts S, Williamson D, Grant C, et al. Implementing hospital-based surveillance for severe acute respiratory infections caused by influenza and other respiratory pathogens in New Zealand. Western Pac Surveill Response J. 2014;5(2):23-30.  https://doi.org/10.5365/wpsar.2014.5.1.004  PMID: 25077034 
  4. Turner N, Pierse N, Bissielo A, Huang Q, Radke S, Baker M, et al. SHIVERS investigation team. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Euro Surveill. 2014;19(34):pii: 20884  https://doi.org/10.2807/1560-7917.ES2014.19.34.20884  PMID: 25188614 
  5. Turner N, Pierse N, Huang QS, Radke S, Bissielo A, Thompson MG, et al. SHIVERS investigation team. Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. Euro Surveill. 2014;19(42):20934.  https://doi.org/10.2807/1560-7917.ES2014.19.42.20934  PMID: 25358042 
  6. Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson M-A, et al. SHIVERS investigation team. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine. 2014;32(29):3687-93.  https://doi.org/10.1016/j.vaccine.2014.04.013  PMID: 24768730 
  7. Shu B, Wu KH, Emery S, Villanueva J, Johnson R, Guthrie E, et al. Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus. J Clin Microbiol. 2011;49(7):2614-9.  https://doi.org/10.1128/JCM.02636-10  PMID: 21593260 
  8. Szewczuk E, Thapa K, Anninos T, McPhie K, Higgins G, Dwyer DE, et al. Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infect Dis. 2010;10(1):113.  https://doi.org/10.1186/1471-2334-10-113  PMID: 20459845 
  9. Pierse N, Kelly H, Thompson M, Bissielo A, Radke S, Huang QS, et al. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected. Vaccine. Forthcoming.
  10. Pebody RG, Warburton F, Ellis J, Andrews N, Thompson C, von Wissmann B, et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill. 2015;20(5):21025.  https://doi.org/10.2807/1560-7917.ES2015.20.5.21025  PMID: 25677050 
  11. Ferdinands JM, Olsho LE, Agan AA, Bhat N, Sullivan RM, Hall M, et al. Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. J Infect Dis. 2014;210(5):674-83.  https://doi.org/10.1093/infdis/jiu185  PMID: 24676207 
  12. McNeil SA, Andrew MK, Ye L, Haguinet F, Hatchette TF, ElSherif M, et al. Investigators of the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN). Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015. Euro Surveill. 2015;20(5):21024.  https://doi.org/10.2807/1560-7917.ES2015.20.5.21024  PMID: 25677052 
  13. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, et al. Centers for Disease Control and Prevention. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep. 2015;64(1):10-5. PMID: 25590680 
  14. Wagner CH. Simpson's paradox in real life. Am Stat. 1982;36(1):46-8.  https://doi.org/10.1080/00031305.1982.10482778 
  15. Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, et al. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine. 2007;25(25):4775-83.  https://doi.org/10.1016/j.vaccine.2007.04.015  PMID: 17499402 
  16. Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58(3):319-27.  https://doi.org/10.1093/cid/cit736  PMID: 24235265 
/content/10.2807/1560-7917.ES.2016.21.1.30101
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error